European Innovation Council

The EIC pilot supports top-class innovators, entrepreneurs, small companies and scientists with bright ideas and the ambition to scale up internationally. It brings together the parts of Horizon 2020 that provide funding, advice and networking opportunities for those at cutting edge of innovation.

David Malo Jean

Director

Past deals in Nordic Europe

Sparrow Quantum

Seed Round in 2023
Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.

Norbite

Grant in 2023
Norbite is a biotech research firm focused on converting plastic waste into sustainable products through an innovative insect-based biorefinery. The company's technology integrates biorefinery and vertical farming methods to process plastic waste, yielding larvae that are bio-refined into proteins suitable for food and feed applications. By offering sustainable solutions, Norbite aims to contribute positively to environmental efforts while providing clients with valuable products and services.

TILT Biotherapeutics

Grant in 2023
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, focused on developing genetically modified oncolytic viruses to improve cancer treatments. Established in 2013, the company aims to enhance tumor T-cell therapies through its patented technology, which utilizes oncolytic viruses to modify the tumor microenvironment and counteract its immune-suppressive properties. TILT Biotherapeutics is advancing several product candidates, including TILT-123, TILT-234, and TILT-321, and plans to translate its innovative approach into clinical trials. The technology is designed to bolster the effectiveness of tumor-infiltrating lymphocyte (TIL) therapies, chimeric antigen receptor (CAR-T) therapies, and checkpoint inhibitors, potentially achieving outcomes in solid tumors similar to those seen in hematological cancers.

TILT Biotherapeutics

Venture Round in 2023
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, focused on developing genetically modified oncolytic viruses to improve cancer treatments. Established in 2013, the company aims to enhance tumor T-cell therapies through its patented technology, which utilizes oncolytic viruses to modify the tumor microenvironment and counteract its immune-suppressive properties. TILT Biotherapeutics is advancing several product candidates, including TILT-123, TILT-234, and TILT-321, and plans to translate its innovative approach into clinical trials. The technology is designed to bolster the effectiveness of tumor-infiltrating lymphocyte (TIL) therapies, chimeric antigen receptor (CAR-T) therapies, and checkpoint inhibitors, potentially achieving outcomes in solid tumors similar to those seen in hematological cancers.

Modvion

Convertible Note in 2023
Modvion AB, founded in 2015 and based in Gothenburg, Sweden, specializes in the design and development of modular wind power towers constructed from renewable composite materials. The company's innovative modular technology simplifies construction logistics by facilitating transportation and installation of towers over 120 meters tall. This approach not only reduces costs associated with traditional steel tower construction but also enhances efficiency in harnessing wind energy. By leveraging engineered wood products, Modvion aims to improve the economic viability of wind power investments for power plant construction businesses, ultimately contributing to a more sustainable energy landscape.

Skyfora

Grant in 2022
Developer of a forecasting software designed to forecast scientific understanding of hurricanes with computer vision and IoT technologies. The company's software utilizes the full resolution of satellite images to improve on conventional, numerical weather forecasting technology, enabling disaster managers to avoid or decrease the catastrophes related to hurricanes.
Aurora Propulsion Technologies Oy provides satellite manufacturers with highly reliable mass produced and high quality, components for attitude (orientation) and orbit control. The vision is to enable small (1- 15 kg) satellite manufacturers to be able to conduct their satellite missions effectively and take their satellites anywhere, be it to Low Earth orbit or other planets in the solar system.

Quanturi

Grant in 2022
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.

QuantrolOx

Venture Round in 2022
QuantrolOx specializes in developing automated machine learning-based control software for quantum technologies, focusing on the tuning, stabilization, and optimization of qubits. By providing robust software solutions, the company aids quantum scientists in achieving stable platforms for experimentation, which enhances the effectiveness of quantum computing applications. This innovative approach allows clients to utilize more cost-effective quantum infrastructure while efficiently implementing standard quantum computing technologies in their operations.

Paptic

Grant in 2022
Paptic is a manufacturing company based in Espoo, Finland, established in April 2015. The company specializes in creating wood-based products that replace traditional paper and plastic, addressing the global challenge of plastic waste. Paptic's innovative bags combine the renewability and recyclability of paper with the functional benefits of plastics, providing a sustainable alternative for consumers and businesses. With a small team of ten employees, Paptic aims to contribute to a more sustainable environment while meeting the everyday needs of customers for plastic bags.

Paptic

Venture Round in 2022
Paptic is a manufacturing company based in Espoo, Finland, established in April 2015. The company specializes in creating wood-based products that replace traditional paper and plastic, addressing the global challenge of plastic waste. Paptic's innovative bags combine the renewability and recyclability of paper with the functional benefits of plastics, providing a sustainable alternative for consumers and businesses. With a small team of ten employees, Paptic aims to contribute to a more sustainable environment while meeting the everyday needs of customers for plastic bags.

GlucoSet

Venture Round in 2022
GlucoSet AS is a medical device company based in Trondheim, Norway, specializing in the design and manufacturing of sensor-based blood glucose monitoring tools for use in Intensive Care Units (ICUs). Founded in 2011, GlucoSet focuses on developing intravascular sensor technology that provides continuous and accurate monitoring of blood glucose levels in critically ill patients. This technology addresses the challenges of elevated and unstable glucose levels in ICU settings, which can lead to costly complications, prolonged hospital stays, and increased mortality rates. By delivering real-time glucose information, GlucoSet's system enables healthcare professionals to effectively manage glucose levels, thereby minimizing the risk of harmful hypoglycemia and improving overall patient outcomes.

Oivi

Grant in 2022
Oivi develops an easy and affordable AI-camera and platform that will identifies diabetic eye-disease. It allows retinal screening at primary care, creating awareness, and maintaining diabetic eye-health for all. The company has a multifaceted team with extensive knowhow on camera and software development. Oivi was founded on 2017 and is headquartered in Oslo, Norway.

Lindhe Xtend

Venture Round in 2022
Lindhe Xtend specializes in the development and sale of user-friendly prostheses and accessories aimed at enhancing the quality of life for amputees. The company's products are designed to provide a natural and flexible experience, utilizing composite materials that allow for adaptability to various terrains. By collaborating closely with users, Lindhe Xtend focuses on creating solutions that enable individuals to navigate daily challenges with ease, promoting a life of freedom and mobility.

sensiBel

Series A in 2022
sensiBel AS, founded in 2016 and located in Oslo, Norway, specializes in the development of ultra-high-sensitivity microphones utilizing optical micro-electro-mechanical system (MEMS) technology. The company focuses on creating microphones that offer optical ultra-low noise performance, enhancing voice control technology without sacrificing acoustic overload point and total harmonic distortion. This innovative approach enables superior speech recognition capabilities and high-quality audio capture, making it a valuable contributor to advancements in voice control applications.

Surgify

Venture Round in 2022
Surgify Medical Oy, founded in 2015 and based in Espoo, Finland, specializes in developing innovative surgical technology aimed at enhancing safety during bone surgeries. The company's flagship product is a neurological burr designed to prevent injuries to nerves and blood vessels, which can occur with traditional surgical drills. This technology is compatible with existing surgical equipment, eliminating the need for additional training for medical personnel. Surgify's solutions have applications in orthopedics and dentistry and are being commercialized in collaboration with Aalto University, with financial support from Tekes, the Finnish Funding Agency for Innovation. The company has also established a partnership with the Neurosurgical Department of Helsinki University Central Hospital to facilitate ongoing communication with clinicians, ensuring that its technology effectively meets the needs of healthcare providers and improves patient outcomes by reducing complications such as bleeding and infections.

CH-Bioforce

Venture Round in 2022
CH-Bioforce provides a revolutionary technology for converting all biomass components into high-value material streams - dissolving pulp, polymeric hemicellulose, and sulphur-free lignin. These valuable biomaterials can replace fossil and food-based raw materials in multiple industries, such as textiles and packaging applications.

Peili Vision

Grant in 2022
Peili Vision Oy is a company based in Helsinki, Finland, that specializes in developing a virtual reality platform designed for neurological rehabilitation. Founded in 2015, the company provides a software solution that enables therapists to create customized training environments for various therapeutic programs, including speech and language pathology, neuropsychology, and occupational therapy. Peili Vision's platform integrates virtual reality technology with data analytics and gamification, allowing healthcare professionals to offer personalized rehabilitation experiences. The system adapts to each patient's needs by analyzing their abilities and progress, delivering valuable insights to therapists to enhance treatment effectiveness. Peili Vision serves both private and public healthcare clients and also operates an additional office in Oulu, Finland.

TILT Biotherapeutics

Grant in 2022
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, focused on developing genetically modified oncolytic viruses to improve cancer treatments. Established in 2013, the company aims to enhance tumor T-cell therapies through its patented technology, which utilizes oncolytic viruses to modify the tumor microenvironment and counteract its immune-suppressive properties. TILT Biotherapeutics is advancing several product candidates, including TILT-123, TILT-234, and TILT-321, and plans to translate its innovative approach into clinical trials. The technology is designed to bolster the effectiveness of tumor-infiltrating lymphocyte (TIL) therapies, chimeric antigen receptor (CAR-T) therapies, and checkpoint inhibitors, potentially achieving outcomes in solid tumors similar to those seen in hematological cancers.
Scandinavian Real Heart is a medical technology company focused on developing an advanced artificial heart designed to assist patients awaiting heart transplants. The company's Total Artificial Heart (TAH) aims to closely replicate the natural pumping action, pressure ratios, and pulse of a healthy heart. With an emphasis on improved functionality compared to existing solutions, the TAH serves as a transitional device for individuals in need of a heart transplant, potentially saving lives and enhancing the quality of care for patients in critical condition.

Syntach

Grant in 2021
Syntach develops a cardiac support device to improve the care of the rapidly-growing number of people with heart failure.

Tada Group AB

Convertible Note in 2021
Tada Group AB, founded in 2016 and headquartered in Stockholm, Sweden, specializes in the manufacturing of medical products, primarily focusing on intravenous solutions. The company offers products such as the Thoor infusion tube, which is designed for efficiency in medical applications. Additionally, Tada Group has developed the ReLink connector, an innovative solution aimed at minimizing complications and costs related to accidental disconnections in IV lines, which is a significant issue in both hospital and homecare environments. Through its product offerings, Tada Group addresses critical challenges in healthcare, enhancing safety and reliability in infusion practices.

N2 Applied

Grant in 2021
N2 Applied is a Norwegian technology company focused on innovative solutions for nitrogen fertilizer production directly on farms. Established in 2010 and headquartered in Oslo, the company has developed a method that allows livestock farmers to convert liquid organic substrates, such as manure and biogas digestate, into fertilizer by extracting nitrogen from the air. This process not only enhances the nitrogen content of the substrate but also mitigates ammonia loss and lowers greenhouse gas emissions. N2 Applied's technology promotes resource efficiency and cost savings for farmers by facilitating local fertilizer production, thus eliminating the need for long supply chains and reliance on fossil-based chemical fertilizers. The company's scalable system contributes to a circular farming model, offering additional benefits such as reductions in methane and ammonia emissions, as well as minimizing odors. N2 Applied operates a test center in Norway and has branches in the Netherlands and the UK, positioning itself within the realms of livestock farming, organic agriculture, and sustainable practices.

CageEye

Grant in 2021
CageEye is an aquatech company based in Oslo, Norway, focused on optimizing seafood production sustainably. By utilizing hydroacoustic technology, CageEye provides salmon farmers with real-time and historical data on fish feeding and behavior. This approach allows for a deeper understanding of the species' needs, enabling farmers to tailor feeding strategies accordingly. As a result, CageEye promotes increased fish growth, reduced feed waste, and enhanced animal welfare, contributing to more responsible and respectful aquaculture practices.

TM Systems

Grant in 2021
TM Systems is an engineering and manufacturing company specializing in industrial air systems and solutions for process industries.

STAC Technology

Venture Round in 2021
STAC Technology is a research and development company based in Hellerup, Denmark, that specializes in sustainable thermal advanced cooling systems utilizing water as a refrigerant. Founded in 2016, the company focuses on transforming the district heating industry by enabling it to provide both heating and cooling services, thereby enhancing its business model. STAC's innovative water vapor-driven turbo compressor technology harnesses thermal energy from water to deliver on-site heating and cooling solutions that are zero-emission and highly efficient. By offering these sustainable solutions, STAC Technology helps clients minimize infrastructure costs, accelerate product development, mitigate project risks, and optimize supply chains while contributing to the fight against climate change.

TM Systems

Venture Round in 2021
TM Systems is an engineering and manufacturing company specializing in industrial air systems and solutions for process industries.

EpiEndo Pharmaceuticals

Series A in 2021
EpiEndo Pharmaceuticals is a privately held Icelandic pharmaceutical company developing a proprietary portfolio of compounds with epithelial barrier enhancing properties. EpiEndo is seed-funded, privately held and in preclinical development.EpiEndo is focusing on chronic respiratory diseases. First clinical trials are planned for the year 2019.EpiEndo is run as an international virtual organization coordinated by a team that consists of founding CEO Dr. Fridrik Runar Gardarsson and COO & CFO Birgir Magnusson, who coordinate a network of specialized service providers.

Invoier

Venture Round in 2021
Invoier is on a mission to help small and medium sized businesses become more competitive by changing the behaviour to access and price working capital. Founded in Stockholm, the financial technology company revolutionised short term financing with the world’s first spot market in real time for invoice trading. Today Invoier offers a platform for businesses in Europe to get paid directly, plan the liquidity and grow its business. Backed by the EIC/European Investment Bank and partnering with some of the biggest investors we are quickly changing how the world sees SME financing. Join us on our mission! Visit: https://www.invoier.com/

Heart Aerospace

Series A in 2021
Heart’s mission is to create the fastest, most affordable and sustainable transportation for regional travel to every corner of the world. Their first aircraft is the ES-19, a nineteen-passenger airliner with an operating range of 400 km. Heart's goal is to have the aircraft certified for commercial operation by 2026.

Handiscover

Seed Round in 2021
Handiscover Sweden AB is an online booking platform focused on providing holiday accommodations for individuals with physical disabilities. Established in 2014 by Sebastien Archambeaud, motivated by personal experience as a father of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover distinguishes itself through a unique classification system that enables users to find suitable accommodations based on their specific mobility needs and levels of physical disability. This community-based approach aims to enhance accessibility in travel, ensuring that individuals with special needs can find and book appropriate lodging options with ease.

Risutec

Venture Round in 2021
Risutec provides solutions for improving forest and agricultural planting and maintenance.

Sparrow Quantum

Non Equity Assistance in 2021
Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.

MedTrace

Venture Round in 2021
MedTrace Pharma A/S is a medical device company based in Kongens Lyngby, Denmark, with additional offices in Boston, Massachusetts, and Uppsala, Sweden. Founded in 2015, the company specializes in the development of innovative solutions for positron emission tomography (PET) imaging. Its flagship product, the MT-100, is an automated system designed for on-site production and infusion of the tracer 15O-water, which enhances the sensitivity of PET scans and improves patient throughput. MedTrace also offers aQuant, an analytical platform that interprets the PET scan results, enabling physicians to obtain accurate blood flow measurements in various clinical applications, including heart studies and tumor vascularization. The integration of these technologies aims to revolutionize PET diagnostic imaging by providing safer and more efficient tools for healthcare professionals.

EpiEndo Pharmaceuticals

Debt Financing in 2021
EpiEndo Pharmaceuticals is a privately held Icelandic pharmaceutical company developing a proprietary portfolio of compounds with epithelial barrier enhancing properties. EpiEndo is seed-funded, privately held and in preclinical development.EpiEndo is focusing on chronic respiratory diseases. First clinical trials are planned for the year 2019.EpiEndo is run as an international virtual organization coordinated by a team that consists of founding CEO Dr. Fridrik Runar Gardarsson and COO & CFO Birgir Magnusson, who coordinate a network of specialized service providers.

Gleechi

Venture Round in 2021
Gleechi AB, founded in 2014 and based in Stockholm, Sweden, specializes in developing software solutions that facilitate natural hand interaction in virtual environments and robotics. The company's innovative technology allows for real-time hand motion interaction, enhancing experiences in virtual reality and gaming. By leveraging advanced computer vision and machine learning algorithms, Gleechi enables realistic hand movements, making it easier for users to engage with virtual training scenarios and artificial hands. The company has received several accolades, including recognition as Super Startup of the Year and Startup of the Year by various organizations, highlighting its impact and leadership in the field of interactive software solutions.

NIL Technology

Venture Round in 2021
NIL Technology ApS is a nanotechnology company based in Kongens Lyngby, Denmark, with a branch in Gothenburg, Sweden. Established in 2006, the company specializes in the optical design, prototyping, and mass production of optical components. NIL Technology offers nanostructured masters for various replication technologies, such as nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product range includes diffractive optical elements, microlens arrays, beam splitters, optical diffusers, and waveguides for augmented and mixed reality applications. The company's solutions cater to diverse sectors, including biotechnology, renewable energy, consumer product packaging, and advanced imaging technologies. By focusing on optical applications for sensors, 3D displays, and smartphones, NIL Technology aims to enable innovative optical solutions for a variety of high-tech industries.

Woodio

Venture Round in 2021
Woodio Oy is a Finnish company that specializes in designing and manufacturing innovative bathroom products, including washbasins, sinks, and tiles, using a proprietary waterproof wood composite material made from real wood chips. Founded in 2015 and headquartered in Helsinki, Woodio focuses on advanced wood-based materials development, offering a range of customizable design options for modern bathrooms. The company's products are sold through its own showroom as well as through constructors and distributors across Europe. Woodio emphasizes sustainability by utilizing fully recyclable biomaterials, promoting environmentally friendly solutions in bathroom design.

Cellugy

Seed Round in 2020
Cellugy is a biotechnology startup focused on creating sustainable alternatives to single-use plastics through the production of 100% natural bio-cellulose. Utilizing a fermentation platform, the company harnesses renewable resources instead of fossil fuels to develop high-quality cellulose that competes effectively in terms of economics and environmental impact. Cellugy's innovative approach allows for the production of various grades and qualities of cellulose, making it applicable across multiple industries, including personal care, packaging, textiles, and food. By offering a more sustainable solution, Cellugy aims to significantly reduce the environmental footprint associated with traditional materials.

Electrochaea

Venture Round in 2020
Electrochaea GmbH develops and commercializes a grid-scale power-to-gas energy storage technology. The company’s biocatalytic power-to-gas technology converts low-cost and stranded electricity into pipeline-grade renewable gas for direct injection into the existing natural gas grid, which is used for on-site power production, heating applications, or transmitted over long distances using existing pipelines. Its technology enables storing large amounts of renewable energy from wind and solar; and represents a solution for utility-scale energy storage, grid balancing, and carbon recycling. Electrochaea GmbH was founded in 2010 and is based in Planegg, Germany with additional operation facilities at Hvidovre, Denmark, and Sacramento, California.

Wavefoil

Grant in 2020
Developer of a retractable bow foil technology designed to reduce fuel consumption and ship motions in waves for marine vessels. The company's foils use a smart retraction mechanism with the use of light but strong composite materials that aid in generating lift when the vessel is moving up and down in waves, enabling clients to have access to a material that facilitates wave propulsion.

Enerpoly

Grant in 2020
Enerpoly is a next-generation energy storage technology company pioneering rechargeable zinc-ion battery chemistry. Enerpoly innovates in battery components, production methods, and designs, and employs agile research and development techniques to rapidly deliver batteries that are suitable for the grid, industrial, commercial, and residential uses.

Faron Pharmaceuticals

Grant in 2020
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Ilya Pharma

Venture Round in 2020
Ilya Pharma AB is a biotechnology company based in Uppsala, Sweden, that specializes in developing biological drugs aimed at treating wounds in skin and mucosa. Founded in 2016, the company focuses on addressing both acute and chronic wounds, particularly those affecting individuals with diabetes. Ilya Pharma employs a unique approach by genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that enhance the healing process of skin injuries. Their innovative drug delivery system utilizes these bacteria as vectors to administer biological drugs directly at the wound site or within the gastrointestinal tract, facilitating accelerated healing in a cost-effective manner. The company’s research and development efforts are rooted in extensive scientific studies conducted at Uppsala University and the Swedish University of Agriculture.

FluoGuide

Grant in 2020
FluoGuide A/S is a Copenhagen-based company that focuses on developing surgical solutions to enhance cancer treatment outcomes. Founded in 2018, the company is known for its product FG001, which utilizes a fluorophore that specifically binds to cancer cells expressing the urokinase receptor. By employing intelligent targeting techniques, FluoGuide aims to improve surgical precision, thereby reducing patient suffering and increasing the chances of successful treatment. Additionally, the company seeks to lower healthcare costs associated with cancer surgeries.

ONiO

Venture Round in 2020
Developer of batteryless microcontrollers intended to convert one IoT device at a time to a battery-free ecosystem. The company's wireless microcontrollers are self-powered and battery-free which harvest energy from their surroundings making health information more accessible and easier to interpret by reducing the barrier between people and healthcare technology, enabling individuals to be more confident about their health and spend more time focusing on everything else.

Evoy

Grant in 2020
Evoy AS designs and manufactures electric propulsion boat systems. The company offers marine electric propulsion systems, including inboard electric propulsion, outboard electric propulsion, and battery modules and ranges for the elimination of global boating emissions. It also offers Evoy ecosystem, which provides climate control, real-time motor data, smart battery management, data dashboard visualization, online connection, automatic identification system, port change capabilities, first stage automation, and assistance services. The company serves boat manufacturing industries. The company was founded in 2018 and is headquartered in Florø, Norway.

OTECHOS

Venture Round in 2020
OTECHOS is a young company (est. 2012) with roots back in industrial engineering and commercialization of new products within the energy – oil & gas industry, machinery and mechanical branches. We follow our innovative and environmentally friendly products from the early stage of idea to their specific markets. The company draws benefits from long experience and from being a small and flexible environment for creativity and knowhow. The founders behind OTECHOS have several technology establishments in their records. All from early stage in year 2000 until today, they founded five technology companies. All have been into mechanical technology / products and machinery. From their first success, the CFT (Coiled Foil Technology) heat exchanger in Pleat AS (www.pleat.no) to the last and most known company, Quickflange AS with its unique cold weld technology for pipe flanges (www.quickflange.com), all which have created a global footprint in the piping industry. Quickflange has received several technology prizes, for instance “Deloitte Technology Fast 500”, “NHO’s Innovation price 2010 (Confederation of Norwegian Enterprises) for innovative technology and business development” and finalist in the “DnB Innovation prize”. From the very first cooperation between the two founders, there always been focus on new technology with a global potential and with IP rights (patented technology). OTECHOS is such a company. The company has now several investors, where the two founders are the major shareholders. The investors, directors of the board and the management are all professionals and have long and wide experience in international business and industry. This will ensure that the rap

OTECHOS

Grant in 2020
OTECHOS is a young company (est. 2012) with roots back in industrial engineering and commercialization of new products within the energy – oil & gas industry, machinery and mechanical branches. We follow our innovative and environmentally friendly products from the early stage of idea to their specific markets. The company draws benefits from long experience and from being a small and flexible environment for creativity and knowhow. The founders behind OTECHOS have several technology establishments in their records. All from early stage in year 2000 until today, they founded five technology companies. All have been into mechanical technology / products and machinery. From their first success, the CFT (Coiled Foil Technology) heat exchanger in Pleat AS (www.pleat.no) to the last and most known company, Quickflange AS with its unique cold weld technology for pipe flanges (www.quickflange.com), all which have created a global footprint in the piping industry. Quickflange has received several technology prizes, for instance “Deloitte Technology Fast 500”, “NHO’s Innovation price 2010 (Confederation of Norwegian Enterprises) for innovative technology and business development” and finalist in the “DnB Innovation prize”. From the very first cooperation between the two founders, there always been focus on new technology with a global potential and with IP rights (patented technology). OTECHOS is such a company. The company has now several investors, where the two founders are the major shareholders. The investors, directors of the board and the management are all professionals and have long and wide experience in international business and industry. This will ensure that the rap

Handiscover

Grant in 2020
Handiscover Sweden AB is an online booking platform focused on providing holiday accommodations for individuals with physical disabilities. Established in 2014 by Sebastien Archambeaud, motivated by personal experience as a father of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover distinguishes itself through a unique classification system that enables users to find suitable accommodations based on their specific mobility needs and levels of physical disability. This community-based approach aims to enhance accessibility in travel, ensuring that individuals with special needs can find and book appropriate lodging options with ease.

ATLANT 3D

Seed Round in 2020
ATLANT 3D Nanosystems is a global pioneer combining unique advanced technologies to enable atomic layer 3D printing. The company was founded in 2018 by Dr. Maksym Plakhotnyuk, Ivan Kundrata, and Prof. Dr. Julien Bachmann with a vision of delivering the first-ever atomic layer 3D printing technology to reshape the future atom by atom. Our state-of-the-art atomic layer 3D printing technology is a true European creation, supported by three major European universities: Technical University of Denmark, Institute of Electrical Engineering Slovak Academy of Sciences, and Friedrich Alexander University Erlangen-Nuremberg.

Neuro Event Labs

Series A in 2020
Neuro Event Labs Oy is a Finnish medical technology company founded in 2015 and based in Tampere. The company specializes in developing artificial intelligence-powered software that monitors epilepsy patients both at home and in clinical settings. Its primary product collects and analyzes accurate data on epilepsy seizures through the use of video and various sensors, leveraging computer vision, smart analytics, and machine learning. This data is relayed to healthcare providers, allowing them to make informed treatment decisions tailored to individual patients. The solution has been crafted in collaboration with leading hospitals in Finland, enhancing its reliability and effectiveness in managing epilepsy care.

Klikkit

Venture Round in 2020
Klikkit is a welfare technology platform that focuses on home care, care homes, and hospitals. It specializes in telehealth platforms, health, healthcare, home care, care center, hospitals, digital innovation, digital solutions, technology trends, innovation, and health care management. Klikkit was founded in the year 2018.

Vital Beats

Seed Round in 2020
Developer of a medical platform intended to deliver clinical decision support for remote care of heart patients with pacemakers. The company's platform leverages machine learning and ethnography to monitor cardiac devices remotely and uses advanced analytics to predict health conditions, enabling chronic patients with digital healthcare that monitors implanted cardiac devices.

MedTrace

Venture Round in 2020
MedTrace Pharma A/S is a medical device company based in Kongens Lyngby, Denmark, with additional offices in Boston, Massachusetts, and Uppsala, Sweden. Founded in 2015, the company specializes in the development of innovative solutions for positron emission tomography (PET) imaging. Its flagship product, the MT-100, is an automated system designed for on-site production and infusion of the tracer 15O-water, which enhances the sensitivity of PET scans and improves patient throughput. MedTrace also offers aQuant, an analytical platform that interprets the PET scan results, enabling physicians to obtain accurate blood flow measurements in various clinical applications, including heart studies and tumor vascularization. The integration of these technologies aims to revolutionize PET diagnostic imaging by providing safer and more efficient tools for healthcare professionals.
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Hypermemo

Grant in 2020
Hypermemo Oy is a Finnish company based in Joensuu, established in 2009, that specializes in developing industrial gas laser equipment specifically for glass processing. The company offers an innovative all-in-one technology known as GLAZER, which enhances various glass treatment operations including cutting, chamfering, engraving, and surface treatment. GLAZER streamlines these processes by utilizing a single laser tool on one table, eliminating the need for chips, liquids, and abrasive powders, as well as the washing phase typically associated with glass processing. Hypermemo's gas laser technology, which employs high-frequency, short pulses, provides superior cutting capabilities compared to traditional lasers, allowing it to effectively compete with mechanical processing methods in the broader market.

Oivi

Grant in 2020
Oivi develops an easy and affordable AI-camera and platform that will identifies diabetic eye-disease. It allows retinal screening at primary care, creating awareness, and maintaining diabetic eye-health for all. The company has a multifaceted team with extensive knowhow on camera and software development. Oivi was founded on 2017 and is headquartered in Oslo, Norway.

Woodio

Grant in 2020
Woodio Oy is a Finnish company that specializes in designing and manufacturing innovative bathroom products, including washbasins, sinks, and tiles, using a proprietary waterproof wood composite material made from real wood chips. Founded in 2015 and headquartered in Helsinki, Woodio focuses on advanced wood-based materials development, offering a range of customizable design options for modern bathrooms. The company's products are sold through its own showroom as well as through constructors and distributors across Europe. Woodio emphasizes sustainability by utilizing fully recyclable biomaterials, promoting environmentally friendly solutions in bathroom design.

Gleechi

Grant in 2020
Gleechi AB, founded in 2014 and based in Stockholm, Sweden, specializes in developing software solutions that facilitate natural hand interaction in virtual environments and robotics. The company's innovative technology allows for real-time hand motion interaction, enhancing experiences in virtual reality and gaming. By leveraging advanced computer vision and machine learning algorithms, Gleechi enables realistic hand movements, making it easier for users to engage with virtual training scenarios and artificial hands. The company has received several accolades, including recognition as Super Startup of the Year and Startup of the Year by various organizations, highlighting its impact and leadership in the field of interactive software solutions.

sensiBel

Grant in 2020
sensiBel AS, founded in 2016 and located in Oslo, Norway, specializes in the development of ultra-high-sensitivity microphones utilizing optical micro-electro-mechanical system (MEMS) technology. The company focuses on creating microphones that offer optical ultra-low noise performance, enhancing voice control technology without sacrificing acoustic overload point and total harmonic distortion. This innovative approach enables superior speech recognition capabilities and high-quality audio capture, making it a valuable contributor to advancements in voice control applications.
EpiEndo Pharmaceuticals is a privately held Icelandic pharmaceutical company developing a proprietary portfolio of compounds with epithelial barrier enhancing properties. EpiEndo is seed-funded, privately held and in preclinical development.EpiEndo is focusing on chronic respiratory diseases. First clinical trials are planned for the year 2019.EpiEndo is run as an international virtual organization coordinated by a team that consists of founding CEO Dr. Fridrik Runar Gardarsson and COO & CFO Birgir Magnusson, who coordinate a network of specialized service providers.

Hafnium Labs

Grant in 2019
Hafnium Labs supports chemicals, energy, and pharma companies by solving one of the biggest challenges in chemistry: Obtaining reliable physical properties fast. From drugs that save our lives, to crop and energy technologies that will save our tomorrow, advances in chemistry change the world. By supporting researchers and engineers working with chemistry we help create a brighter future. We have developed a breakthrough system for combining state-of-the-art predictive methods, such as quantum chemistry and AI, with experimental physical property data. By intelligently and transparently using all available information, we provide the most accurate physical property predictions and quantify the uncertainty, so you know how reliable each prediction is.​ Our Q-props™ tools support decision making from molecular discovery to process optimization. ​Check out our website and reach out to learn more about how to use Q-props™ in your company.

EIC Norway

Grant in 2019
Innovasjon Norges konto for informasjon om European Innovation Council, under EUs rammeprogram for forskning og innovasjon.

Picterus

Venture Round in 2019
Picterus is an app under development designed to diagnose Jaundice in newborns. Untreated jaundice in newborns is responsible for 114,000 deaths and 65,000 permanent brain damages each year. More than three quarters of these deaths occur in the poorest regions of the world, in sub-Saharan Africa and south Asia. Cheap treatment is available through e.g. sunlight, but the diagnostic devices in use today cost around 10,000 dollars, making them practically unavailable in low-resource settings.

Wimao

Venture Round in 2019
Wimao is passionate about ecological composites. Their operations are based on patented technology. They work to promote a circular economy and to find new ways of utilizing recycled raw materials and industrial side streams. Their company was established in 2016 to commercialize the patented production technology. In 2018, after careful product and process development, their first production plant became operational in the Kukkuroinmäki area in Lappeenranta, where they also work in close collaboration with (waste management company) Etelä-Karjalan Jätehuolto Oy.

EpiEndo Pharmaceuticals

Venture Round in 2019
EpiEndo Pharmaceuticals is a privately held Icelandic pharmaceutical company developing a proprietary portfolio of compounds with epithelial barrier enhancing properties. EpiEndo is seed-funded, privately held and in preclinical development.EpiEndo is focusing on chronic respiratory diseases. First clinical trials are planned for the year 2019.EpiEndo is run as an international virtual organization coordinated by a team that consists of founding CEO Dr. Fridrik Runar Gardarsson and COO & CFO Birgir Magnusson, who coordinate a network of specialized service providers.

Wimao

Grant in 2019
Wimao is passionate about ecological composites. Their operations are based on patented technology. They work to promote a circular economy and to find new ways of utilizing recycled raw materials and industrial side streams. Their company was established in 2016 to commercialize the patented production technology. In 2018, after careful product and process development, their first production plant became operational in the Kukkuroinmäki area in Lappeenranta, where they also work in close collaboration with (waste management company) Etelä-Karjalan Jätehuolto Oy.

ONEiO

Grant in 2019
ONEiO, developed by Service-Flow Oy, is a cloud-based software solution designed to streamline digital transformation by integrating various processes and platforms into a cohesive system. This innovative platform provides an online integration service that connects information technology service management (ITSM) tools, allowing users to maintain existing tools while independently enhancing their processes. ONEiO facilitates seamless integration with suppliers, vendors, and other essential functions, making it easier for organizations to digitalize their service processes. Founded in 2011 and headquartered in Helsinki, Finland, Service-Flow also has a presence in London, offering a subscription-based service that enables companies to connect, configure, and run their operations efficiently within a single day.
SSH Communications Security Oyj specializes in enterprise cybersecurity solutions, primarily serving financial institutions and various organizations globally. Founded in 1995 by Tatu Ylönen, the company is recognized for creating the Secure Shell protocol, a crucial standard for securing data in transit. Its product offerings include PrivX for streamlined access management across multi-cloud and serverless environments, Universal SSH Key Manager for managing SSH keys and certificates, Tectia SSH for secure file transfers and remote administration, and NQX Firewall for high-security applications. The company supports a diverse client base of over 3,000 customers, providing both software and professional services. SSH Communications Security operates across multiple regions, including the Americas, APAC, Europe, the Middle East, and Africa, with a significant revenue portion stemming from Finland.

Biomendex

Grant in 2019
They at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos™, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive.

Ladimo

Grant in 2019
LaDiMo Oy, founded in 2015 and based in Espoo, Finland, specializes in developing the Ladimo Smarter Vision technology, a real-time 3D point cloud acquisition solution. The company builds upon innovative technology initially created at Aalto University in 2012 by Jorma Palmén. By integrating photogrammetry, laser technology, and mathematical modeling, Ladimo offers a novel approach to generating high-precision point cloud data. This technology is particularly applicable in machine vision fields, including collaborative robots, industrial automation, automated guided vehicles, and various virtual, augmented, and mixed reality applications.

RePack

Grant in 2019
RePack manufactures and sells reusable and recyclable packaging bags for individuals and clothing brands worldwide. It offers polypropylene, polyethylene, and cardboard packaging bags. The company’s bags can be returned for recycling after the use, and the customer gets rewarded with voucher for the returned bag, which can be used at the time of next purchase at any RePacking store. It sells its products online. RePack was founded in 2013 and is based in Helsinki, Finland with a facility in the United States.

Aiforia

Grant in 2019
Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performance cloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields.

Enerpoly

Grant in 2019
Enerpoly is a next-generation energy storage technology company pioneering rechargeable zinc-ion battery chemistry. Enerpoly innovates in battery components, production methods, and designs, and employs agile research and development techniques to rapidly deliver batteries that are suitable for the grid, industrial, commercial, and residential uses.

KINE

Grant in 2018
KINE specializes in robotics, focusing on the design and provision of robotic systems for various industrial applications globally. In addition to offering these advanced robotic solutions, KINE provides maintenance services to ensure optimal performance and longevity of the systems. The company also delivers training programs for users, enabling them to effectively operate and utilize the robotic technology in their operations.

Karsa

Grant in 2018
Karsa Ltd. is a Finnish company founded in 2016, specializing in the development of advanced touchless detectors for explosives detection. The company focuses on providing solutions for security applications, particularly in transportation and logistics, with products designed for screening luggage and parcels at airports, railway stations, and other public buildings. Karsa's technology is capable of detecting a range of chemical threats, including explosives, drugs, and pesticides in various matrices, thereby addressing critical security challenges. By offering both complete detection systems and integral components, Karsa aims to enhance safety and security in diverse environments through innovative research and user-oriented solutions.

Imaqen

Grant in 2018
Imaqen Ltd. is a Finnish healthcare technology company developing a new pre-screening solution for early detection of cancer. The innovation offers a non-invasive patient examination and it is suitable for use in wide range of healthcare facilities. The utilised method is protected by patents. Their team consists of experienced diagnostic imaging and clinical research professionals with solid track records in successful product development and global sales and marketing.

Medicortex

Grant in 2018
Medicortex Finland is focused on developing a non-invasive, point-of-care diagnostic test for Traumatic Brain Injury (TBI) and concussions. Traditional diagnostic methods, such as CT and MRI scans, struggle to accurately diagnose mild TBIs. To address this, Medicortex is identifying brain injury biomarkers that can be detected from urine and saliva, with plans to incorporate these biomarkers into a hand-held diagnostic kit that provides rapid and reliable results without the need for medical professionals' interpretation. The company aims to collaborate with larger diagnostic firms for manufacturing and distribution. Its target customers include hospitals, emergency rooms, paramedics, military personnel, sports teams, pharmaceutical companies, and insurance providers. Medicortex has achieved significant milestones, including reaching Phase II clinical studies for its biomarker and receiving grant funding from the US Department of Defense, the European Union, and the Finnish Government.

Valtavalo

Grant in 2018
Valtavalo Ltd, founded in 2008, specializes in the development, manufacture, and supply of energy-efficient LED lighting solutions in Finland and internationally. As the largest LED tube manufacturer in the Northern Countries, Valtavalo focuses on high-volume production and large clients, allowing the company to offer competitive pricing on advanced lighting technologies that were previously considered too costly. Their product line features long-lifetime LED lighting tubes with replaceable light sources, which significantly reduce energy consumption and lower both installation and maintenance costs for users.

Desentum

Grant in 2018
Desentum Oy is a biopharmaceutical company based in Finland that focuses on developing innovative hypoallergenic vaccines aimed at treating various allergies, including those caused by pollen, pets, and certain food proteins. Established in 2011, Desentum employs a unique approach to allergy immunotherapy by altering the immune system's response to allergens, promoting tolerance instead of hypersensitivity. The company leverages its research into the molecular mechanisms behind allergic reactions to design effective vaccines that aim to provide long-term relief for patients suffering from allergic symptoms. By utilizing recombinant allergens modified to suppress histamine release during treatment, Desentum seeks to minimize adverse effects and streamline the desensitization process, ultimately addressing the social and economic burdens associated with allergies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.